Skip to search formSkip to main contentSkip to account menu
Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation.
View on PubMed
Respective Performance of 18F-FDG PET and Radiolabeled Leukocyte Scintigraphy for the Diagnosis of Prosthetic Valve Endocarditis
TLDR
18F-FDG PET offers high sensitivity for the detection of active infection in patients with suspected PVE and inconclusive echocardiography results and leukocyte scintigraphy offers a higher specificity, however, than 18F- FDG PET for diagnosis of IE and should be considered in cases of inconclusive 18F–Li PET findings or in the first 2 mo after cardiac surgery.
View on Publisher
Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI
TLDR
In vivo MRI revealed that at 24 h postinjection, immunomicelles provided a 79% increase in signal intensity of atherosclerotic aortas in ApoE−/− mice compared with only 34% using untargeted micelles and no enhancement using gadolinium–DTPA.
View on Publisher
Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography
TLDR
Macrophages in atherosclerotic plaques of rabbits can be detected with a clinical X-ray computed tomography (CT) scanner after the intravenous injection of a contrast agent formed of iodinated nanoparticles dispersed with surfactant, which may become an important adjunct to the clinical evaluation of coronary arteries with CT.
View on Nature
Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging.
TLDR
Use of combined early- and late-perfusion MR imaging sequences helps to distinguish AMI from myocarditis.
View on PubMed
Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis
TLDR
This EANM position paper might indeed be a first step towards "official" guidelines on atherosclerosis imaging with PET, which should provide a basis for standardized clinical Atherosclerosis PET imaging protocols, which are subject to further and continuing improvement.
View on Springer
Variability and Uncertainty of 18F-FDG PET Imaging Protocols for Assessing Inflammation in Atherosclerosis: Suggestions for Improvement
TLDR
Optimized protocols can significantly reduce the measurement errors in wall activity estimates, but PET systems with higher spatial resolution and advanced partial-volume corrections will be required to accurately assess plaque inflammation from 18F-FDG PET.
View on Publisher
Magnetic resonance imaging of vulnerable atherosclerotic plaques: Current imaging strategies and molecular imaging probes
TLDR
This review focuses on MR imaging strategies for the detection and evaluation of atherosclerotic plaques and their composition and highlights recent advancements in the development of MR pulse sequences, computer image analysis, and the use of commercially available MR contrast agents for plaque characterization.
View on Wiley
FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC
TLDR
This position paper aims to set an internationally accepted standard for FDG-PET/CT(A) imaging and reporting of LVV and PMR.
View on Springer
A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European…
TLDR
The role and the correct use of echocardiography, radionuclide imaging with 18 F-fluorodeoxyglucose positron emission tomography and cardiovascular magnetic resonance imaging for the evaluation and management of patients with known or suspected cardiac sarcoidosis is illustrated.
View on Springer
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License